David Grainger
David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space.He was formerly with Index Ventures, an international venture capital firm with offices in London, Geneva and San Francisco, in the firm's life sciences practice. He also writes for Forbes.com on topics related to the pharmaceutical industry. Provided by Wikipedia
Showing 1 - 3 results of 3 for search 'David Grainger', query time: 0.02s
Refine Results
-
1
The Value of Vaccines: A Tale of Two Parts by Nathan Fox, Philip Adams, David Grainger, Jennifer Herz, Carolyn Austin
Published 2022-11-01
Article -
2
Blue hydrogen must be done properly by Jostein Pettersen, Rosetta Steeneveldt, David Grainger, Tyler Scott, Louise‐Marie Holst, Espen Steinseth Hamborg
Published 2022-09-01
Article -
3